The Effects of Multiple Doses of Baricitinib on the Pharmacokinetics of a Single Dose of an Oral Contraceptive in Healthy Female Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2017
Price : $35 *
At a glance
- Drugs Baricitinib (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Diabetic nephropathies; Pregnancy; Psoriasis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Jul 2013 New trial record